A dose escalation phase 1 study of radiotherapy (RT) in combination with anti-cytotoxic-T-lymphocyte-associated antigen 4 (CTLA-4) monoclonal antibody ipilimumab (Ipi) in patients (pts) with metastatic melanoma

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 27; p. vi383
Main Authors	Boutros, C., Mateus, C., Routier, E., Chouaib, S., Libenciuc, C., Reigneau, M., Girault, I., Caramella, C., Hibat, S., Vagner, S., Tao, Y.G., Chaput, N., Adam, J., Soria, J.-C., Eggermont, A., Deutsch, E., Robert, C.
Format	Journal Article
Language	English
Published	Elsevier Ltd 01.10.2016
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534 1569-8041
DOI:	10.1093/annonc/mdw379.12